Burgess Laboratory

Publications

Click to view citations
(as of 12/25/2015)

Books

  1. D.J. Burgess. Injectable Dispersed Systems, Formulation, Processing and Performance. Ed. D.J. Burgess, Drugs and The Pharmaceutical Sciences Series, Marcel Dekker, New York, (2005).
  2. J. Wright and D.J. Burgess. Advances in Delivery Science and Technology: Long Acting Injections and Implants, CRS Press, Springer, (2012). http://dx.doi.org/10.1007/978-1-4614-0554-2

Book chapters (31)

  1. M. Kastellorizios, N. Tipnis, D.J. Burgess. Foreign body reaction to subcutaneous implants. (2015). Immune Response to Biosurfaces, Chapter 6. pp. 93-103 http://dx.doi.org/10.1007/978-3-319-18603-0_6
  2. M. Kapoor D.J. Burgess. Targeted delivery of nucleic acid therapeutics via nonviral vectors. (2015) Targeted Drug Delivery: concepts and Design, 271-312 DOI: 10.1007/978-3-319-11355-5_8
  3. J. Tsung and D.J. Burgess. Biodegradable Polymers in Drug Delivery Systems. In “Fundamentals and Applications of Controlled Release Drug Delivery”. Eds. M. Rathbone, R. Siegel, and J. Shipmann. CRS Press, Springer. Part 2, pp. 107-123, (2012). DOI:10.1007/978-1-4614-0881-9_5
  4. M. Kastellorizios and D.J. Burgess. In vitro Drug Release Testing and In Vivo/In Vitro Correlation for Long Acting Implants and Injections. In "Long acting injections and implants”. Eds. J. Wright and D.J. Burgess. CRS Press, Springer. Chapter 23, pp. 475-504 (2012). DOI:10.1007/978-1-4614-0554-2_23
  5. S. Kumar and D.J. Burgess. Nanosuspension: Controlled Release Science and Technology. In “Long acting injections and implants”. Eds. J. Wright and D.J. Burgess. CRS Press, Springer. Chapter 13, pp. 239-262 (2012). DOI:10.1007/978-1-4614-0554-2_13
  6. J. Morais and D.J. Burgess. Micro- and Nano-emulsion Technologies (Controlled Release Parenteral Drug Delivery Systems). In “Long acting injections and implants”. Eds. J. Wright and D.J. Burgess. CRS Press, Springer. Chapter 12, pp. 221-238 (2012). DOI:10.1007/978-1-4614-0554-2_12
  7. X. Xu and D.J. Burgess. Liposomes as Carriers for Controlled Drug Delivery. In “Long acting injections and implants”. Eds. J. Wright and D.J. Burgess. CRS Press, Springer. Chapter 11, pp. 195-220 (2012). DOI:10.1007/978-1-4614-0554-2_11
  8. Y. Wang and D.J. Burgess. Microsphere Technology. In “Long acting injections and implants”. Eds. J. Wright and D.J. Burgess. CRS Press, Springer. Chapter 10, pp. 167-194 (2012). DOI:10.1007/978-1-4614-0554-2_10
  9. J. Shen and D.J. Burgess. Drugs for Long Acting Injections and Implants. In “Long acting injections and implants”. Eds. J. Wright and D.J. Burgess. CRS Press, Springer. Chapter 5, pp. 73-92 (2012). DOI:10.1007/978-1-4614-0554-2_5
  10. J. Wright and D.J. Burgess. An Introduction of Long Acting Injections and Implants. In “Long acting injections and implants”. Eds. J. Wright and D.J. Burgess. CRS Press, Springer. Chapter 1, pp. 1-10 (2012). DOI:10.1007/978-1-4614-0554-2_1
  11. D.J. Burgess. and M. Kapoor, Quantum dot labeling for assessment of intracellular trafficking of therapeutically active molecules. In “Organelle-Specific Pharmaceutical Nanotechnology”. Ed. V. Weissig, G.G.M. D’Souza, John Wiley and Sons. Chapter 27, pp. 535-568 (2010).
  12. Y. Wang and D.J. Burgess. Drug-device combination products. In “Drug-device combination products – delivery technologies and applications”. Ed. Andrew Lewis, Woodhead Publishing Limited and CRC press, Cambridge, UK, Chapter 1, pp. 3-20 (2010).
  13. S. Verma and D.J. Burgess. Solid Nanosuspensions – The Emerging Technology and Pharmaceutical Applications as Nanomedicine. In "Pharmaceutical Suspensions: From Formulation Development to Manufacturing", Eds. A. Kulshreshtha, O.N. Singh and G. Michael Wall. Chapter 10, pp 285 – 318 AAPS Press, Springer, NY. (2010).
  14. A. Rawat and D.J. Burgess. Parenteral Delivery. In “Biodrug Delivery Systems: Fundamentals, Applications and Clinical Development," Eds. M. Morishita and K. Park. Informa Healthcare. Chapter 5, pp. 50-68 (2009).
  15. B.S. Zolnik, and D.J. Burgess. In Vitro-In Vivo Correlation for Parenteral Dosage Forms. In “Biopharmaceutics Applications in Drug Development”, Eds. R. Krishna and L. Yu Springer Science+Business Media, Inc., New York, NY. Chapter 11, pp. 336-351 (2008).
  16. J. Jiao and D.J. Burgess. Multiple Emulsion Stability: Pressure Balance and Interfacial Film Strength. In “Multiple Emulsions: Technology and Applications”, Ed. A Aserin, Wiley Series on Surface and Interfacial Chemistry, John Wiley and Sons, Inc. Hoboken, New Jersey. Chapter 1, pp.1- 27 (2007).
  17. D.J. Burgess. Physical stability of dispersed systems. In “Injectable Dispersed Systems, Formulation, Processing and Performance”. Ed. D.J. Burgess, Drugs and The Pharmaceutical Sciences Series, Marcel Dekker, New York, NY. Chapter 1, pp. 1-37(2005).
  18. J. Jiao and D.J. Burgess. Characterization and analysis of dispersed systems. In “Injectable Dispersed Systems, Formulation, Processing and Performance”. Ed. D.J. Burgess, Drugs and The Pharmaceutical Sciences Series, Marcel Dekker, New York, Chapter 3, pp. 77-123 (2005).
  19. N. Chidambaram and D.J. Burgess. Emulsions, design and manufacturing. In “Injectable Dispersed Systems, Formulation, Processing and Performance”. Ed. D.J. Burgess, Drugs and The Pharmaceutical Sciences Series, Marcel Dekker, New York, Chapter 7, pp. 213-248 (2005).
  20. S.D. Patil and D.J. Burgess. Liposomes, Design and manufacturing. In “Injectable Dispersed Systems, Formulation, Processing and Performance”. Ed. D.J. Burgess, Drugs and The Pharmaceutical Sciences Series, Marcel Dekker, New York, Chapter 8, pp. 249-303 (2005).
  21. D.J. Burgess and A.J. Hickey. Microcapsules, design and manufacturing. In “Injectable Dispersed Systems, Formulation, Processing and Performance”. Ed. D.J. Burgess, Drugs and The Pharmaceutical Sciences Series, Marcel Dekker, New York, Chapter 9, pp. 305 -352 (2005).
  22. A. Radwick and D.J. Burgess. Proteins as microencapsulating agents for pharmaceutical applications. In "Protein-based Films and Coatings". Editor: Gennadios, Aristippos Publisher: CRC Press LLC, Boca Raton, Fla; pp. 341- 366(2002).
  23. D.J. Burgess and A.J. Hickey. Microsphere technology and applications. In "Encyclopedia of Pharmaceutical Technology," J. Swarbrick and J.C. Boylan, Eds.; Marcel Dekker, Inc., New York and Basel, (2000) online.
  24. D.J. Burgess. Colloids and colloid drug delivery systems. In "Encyclopedia of Pharmaceutical Technology," J. Swarbrick and J.C. Boylan, Eds.; Marcel Dekker, Inc., New York and Basel, (2000) online.
  25. D.J. Burgess and A.J. Hickey. Microsphere technology and applications. In "Encyclopedia of Pharmaceutical Technology," J. Swarbrick and J.C. Boylan, Eds.; Marcel Dekker, Inc., New York and Basel, (1994) Vol 10, pp. 1-29.
  26. D.J. Burgess and N.O. Sahin. Interfacial rheology of β- casein solutions. In "Structure and Flow in Surfactant Solutions", C.A. Herb and R.K. Prud'homme Eds.; ACS symposium Series (1994) Chapter 27, pp. 380-393. (Original Research Article)
  27. D.J. Burgess. Complex coacervation: microcapsule formation: In "Soluble Polymer Complexes", Dubin, Bock, Davis, Schultz and Thies Eds.; Springer-Verlag, Heidelberg, Germany. (1994) pp. 285-300. (Original Research Article)
  28. D.J. Burgess. Drug delivery aspects of biotechnology. In "Biotechnology and the Practice of Pharmacy." J.M. Pezzuto, M.E. Johnson and H.R. Manasse, Eds.; VCH Publications, New York, NY (1993) pp. 116-151.
  29. D.J. Burgess. Colloids and colloid drug delivery systems. In "Encyclopedia of Pharmaceutical Technology," J. Swarbrick and J.C. Boylan, Eds.; Marcel Dekker, Inc., New York and Basel, (1990) Volume 3, Chapter 2, pp. 31-63.
  30. S.S. Davis, L. Illum, D.J. Burgess, J. Ratcliff and S.N. Mills. Microspheres as controlled release systems for parenteral and nasal administration. In "Controlled Release Technology". P.I. Lee and W.R. Good Eds.; ACS Symposium Series, American Chemical Society, Washington, DC (1987), Vol. 348, pp. 201 214. (Original Research Article)
  31. D.J. Burgess and J.E. Carless. Complex coacervate formation between acid and alkaline processed gelatins. In "Columbic Interactions in Macromolecular Systems," F.E. Bailey and A. Eisenberg Eds. ACS Symposium Series, American Chemical Society, Washington, DC, (1986), Vol. 302, Chapter 21, pp. 251 260. (Original Research Article)

Peer-reviewed articles (155)

  1. D. J. Burgess. Pharmaceutical interfaces: drug development, performance, regulation and e-health. (2015) Asian Journal of Pharmaceutical Sciences. In Press. http://dx.doi.org/10.1016/j.ajps.2015.10.003
  2. R. Jog, S. Kumar, J. Shen, N. Jugade, D.C.T. Tan, R. Gokhale, D.J. Burgess, Formulation design and evaluation of amorphous ABT-102 nanoparticles. (2015) International Journal of Pharmaceutics, 498(1-2), pp. 153-169 http://dx.doi.org/10.1016/j.ijpharm.2015.12.033
  3. J. Shen, K. Lee, S. Choi, W. Qu, Y. Wang, D.J. Burgess. A reproducible accelerated in vitro release testing method for PLGA microspheres. (2015) International Journal of Pharmaceutics. 498(1-2), pp. 274-282 http://dx.doi.org/10.1016/j.ijpharm.2015.12.031
  4. J. Shen, D.J. Burgess. In vitro–in vivo correlation for complex non-oral drug products: Where do we stand? (2015) Journal of Controlled Release. 219, pp.644-651 http://dx.doi.org/10.1016/j.jconrel.2015.09.052
  5. J. Shen, S. Choi, W. Qu, Y. Wang, D.J. Burgess. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres. (2015) Journal of Controlled Release. 218, pp. 2-12 http://dx.doi.org/10.1016/j.jconrel.2015.09.051
  6. B. Gu, Y. Wang, D.J. Burgess. In vitro and in vivo performance of dexamethasone loaded PLGA microspheres prepared using polymer blends. (2015) International Journal of Pharmaceutics. 496(2), pp. 534-540 http://dx.doi.org/10.1016/j.ijpharm.2015.10.056
  7. B. Gu, D.J. Burgess. Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach. (2015) International Journal of Pharmaceutics. 495(1), pp. 393-403 http://dx.doi.org/10.1016/j.ijpharm.2015.08.089
  8. A.P. Costa, X. Xu, M. Khan, D.J. Burgess. Liposome Formation Using a Coaxial Turbulent Jet in Co-Flow. (2015) Pharmaceutical Research. pp. 1-13 http://dx.doi.org/10.1007/s11095-015-1798-8
  9. M. Kastellorizios, F. Papadimitrakopoulos, D.J. Burgess. Multiple tissue response modifiers to promote angiogenesis and prevent the foreign body reaction around subcutaneous implants. (2015) Journal of Controlled Release. 214, pp. 103-111 http://dx.doi.org/10.1016/j.jconrel.2015.07.021
  10. Y. Wang, S. Vaddiraju, B. Gu, F. Papadimitrakopoulos, D.J. Burgess. Foreign Body Reaction to Implantable Biosensors Effects of Tissue Trauma and Implant Size. (2015) Journal of Diabetes Science and Technology, 9(5), pp. 966-977 http://dx.doi.org/10.1177/1932296815601869
  11. M. Kastellorizios, N. Tipnis, F. Papadimitrakopoulos, D.J. Burgess. Drug Distribution in Microspheres Enhances Their Anti-Inflammatory Properties in the Gottingen Minipig. (2015) Molecular Pharmaceutics, 12(9), pp. 3332-3338 http://dx.doi.org/10.1021/acs.molpharmaceut.5b00326
  12. M. Kastellorizios, D.J. Burgess. Continuous Metabolic Monitoring Based on Multi-Analyte Biomarkers to Predict Exhaustion. (2015) Scientific Reports, 5 http://dx.doi.org/10.1038/srep10603
  13. S. Kumar, J. Shen, B. Zolnik, N. Sadrieh, D.J. Burgess. Optimization and dissolution performance of spray-dried naproxen nano-crystals. (2015) International Journal of Pharmaceutics. 486(1), pp. 159-166 http://dx.doi.org/10.1016/j.ijpharm.2015.03.047
  14. S. Kumar, R. Jog, J. Shen, B. Zolnik, N. Sadrieh, D.J. Burgess. Formulation and Performance of Danazol Nano-crystalline Suspensions and Spray Dried Powders. (2015). Pharmaceutical Research. 32(5), pp. 1694-1703 http://dx.doi.org/10.1007/s11095-014-1567-0
  15. M. Kastellorizios, F. Padimitrakopoulos, D.J. Burgess. Prevention of foreign body reaction in a pre-clinical large animal model. (2015). Journal of Controlled Release, 202, pp. 101-107. http://dx.doi.org/10.1016/j.jconrel.2015.01.038
  16. S. Kumar, R. Jog, J. Shen, B. Zolnik, N. Sadrieh, D.J. Burgess. In Vitro and In Vivo performance of different sized spray-dried crystalline itraconazole. (2014) Journal of Pharmaceutical Sciences. 104(9), pp. 3018-3028. http://dx.doi.org/10.1002/jps.24155
  17. S. Kumar, J. Shen, D.J. Burgess. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole. (2014) Journal of Controlled Release. 192, pp. 95-102. http://dx.doi.org/10.1016/j.jconrel.2014.06.059
  18. S. Kumar, R. Gokhale, D.J. Burgess. Sugars as bulking agents to prevent nano-crystal aggregation during spray or freeze-drying. (2014) International Journal of Pharmaceutics. 471(1), pp. 303-311. http://dx.doi.org/10.1016/j.ijpharm.2014.05.060
  19. S. Kumar, D.J. Burgess. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions. (2014) International Journal of Pharmaceutics. International Journal of Pharmaceutics. 466(1), pp. 223-232. http://dx.doi.org/10.1016/j.ijpharm.2014.03.021
  20. J. Morais, D.J. Burgess. Vitamin E nanoemulsions characterization and analysis. (2014) International Journal of Pharmaceutics. 465(1), pp. 455-463. http://dx.doi.org/10.1016/j.ijpharm.2014.02.034
  21. S. Kumar, R. Gokhale, D.J. Burgess. Quality by Design Approach to Spray Drying Processing of Crystalline Nanosuspensions. (2014) International Journal of Pharmaceutics. 464(1-2), pp. 234-242. http://dx.doi.org/10.1016/j.ijpharm.2013.12.039
  22. S. Kumar, X. Xu, R. Gokhale, D.J. Burgess. Formulation Parameters of Crystalline Nanosuspensions on Spray Drying Processing: A DoE Approach. (2014) International Journal of Pharmaceutics. 464(1-2), pp. 34-45. http://dx.doi.org/10.1016/j.ijpharm.2014.01.013
  23. Y. Wang, B. Gu, D.J. Burgess. Microspheres Prepared with PLGA Blends for Delivery of Dexamethasone for Implantable Medical Devices. (2014) Pharmaceutical Research. 31(2), pp. 373-381. http://dx.doi.org/10.1007/s11095-013-1166-5
  24. A.P. Costa, X. Xu, D.J. Burgess. Freeze-Anneal-Thaw Cycling of Unilamellar Liposomes: Effect on Encapsulation Efficiency. (2014) Pharmaceutical Research. 31(1), pp. 97-103. http://dx.doi.org/10.1007/s11095-013-1135-z
  25. S. Vaddiraju, A. Legassey, L. Qiang, Y. Wang, D.J. Burgess, F. Papadimitrakopoulos. Enhancing the Sensitivity of Needle-Implantable Electrochemical Glucose Sensors via Surface Rebuilding. (2013) Journal of Diabetes Science and Technology. 7(2), pp. 441-451. http://dx.doi.org/10.1177/193229681300700221
  26. Y. Wang, D.J. Burgess. Influence of storage temperature and moisture on the performance of microsphere/hydrogel composites. (2013) International Journal of Pharmaceutics. 454(1), pp. 310-315. http://dx.doi.org/10.1016/j.ijpharm.2013.06.012
  27. H. Kim, C. Babu, D.J. Burgess. Quantification of protonation in organic solvents using solution NMR spectroscopy: Implication in salt formation. (2013) International Journal of Pharmaceutics. 448(1), pp. 123-131 http://dx.doi.org/10.1016/j.ijpharm.2013.03.040
  28. J. Shen, D.J. Burgess. In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. (2013) Drug Delivery and Translational Research. 3(5), pp.409-415. http://dx.doi.org/10.1007/s13346-013-0129-z
  29. Y. Wang, F. Papadimitrakopoulos, D.J. Burgess. Polymeric “smart” coatings to prevent foreign body response to implantable biosensors. (2013) Journal of Controlled Release. 169(3), pp. 341-347. http://dx.doi.org/10.1016/j.jconrel.2012.12.028
  30. M. Kapoor, D.J. Burgess. Cellular Uptake Mechanisms of Novel Anionic siRNA Lipoplexes. (2013) Pharmaceutical Research. 30(4), pp. 1161-1175 http://dx.doi.org/10.1007/s11095-012-0952-9
  31. R.A. Croce, S.S. Vaddiraju, J. Kondo, Y. Wang, L. Zuo, K. Zhu, S.K. Islam, D.J. Burgess,F. Papadimitrakopoulos, and F.C. Jain. A miniaturized transcutaneous system for continuous glucose monitoring. (2013) Biomedical Microdevice, 15(1), pp. 151-160. http://dx.doi.org/10.1007/s10544-012-9708-x
  32. Y. Wang, S. Vaddiraju, L. Qiang, X. Xu, F. Papadimitrakopoulos, D. J. Burgess. Effect of dexamethasone-loaded poly(lactic-co-glycolic acid) microsphere/poly(vinyl alcohol) hydrogel composite coatings on the basic characteristics of implantable glucose sensors. (2012) Journal of Diabetes Science and Technology, 6(6), pp. 1445-1453. http://www.ncbi.nlm.nih.gov/pubmed/23294792
  33. Y. Wang, S. Vaddiraju, L. Qiang, D. J. Burgess, and F. Papadimitrakopoulos. Microsphere Erosion in Outer Hydrogel Membranes Creating Macroscopic Porosity to Counter Biofouling-Induced Sensor Degradation. (2012) Analytical Chemistry, 84(20), pp. 8837-8845. http://dx.doi.org/10.1021/ac3022423
  34. A.K. Salem, S.D. Patil, D.J. Burgess. Recent progress in non-viral nucleic acids delivery. (2012) Int J Pharm, 427(1), pp. 1-2. http://dx.doi.org/10.1016/j.ijpharm.2011.11.029
  35. X. Xu, A.P. Costa, M.A. Khan, D.J. Burgess. Application of quality by design to formulation and processing of protein liposomes. (2012) Int J Pharm, 434(1-2), pp. 349-359. http://dx.doi.org/10.1016/j.ijpharm.2012.06.002
  36. A. Rawat, U. Bhardwaj, D.J. Burgess. Comparison of in vitro–in vivo release of Risperdal® Consta® microspheres. (2012) Int J Pharm, 434(1-2), pp 115-121. http://dx.doi.org/10.1016/j.ijpharm.2012.05.006
  37. A.P. Costa, X. Xu, D.J. Burgess. Langmuir Balance Investigation of Superoxide Dismutase Interactions with Mixed-Lipid Monolayers. (2012) Langmuir, 28(26), 10050-10056. http://dx.doi.org/10.1021/la301614t
  38. M. Kapoor, D.J. Burgess. Efficient and Safe Delivery of siRNA using Anionic Lipids – Formulation Optimization Studies. International Journal of Pharmaceutics, (2012) 432 (1-2), 2012, 80-90. http://dx.doi.org/10.1016/j.ijpharm.2012.04.058
  39. J. Shen, D.J. Burgess. Accelerated in-vitro release testing methods for extended-release parenteral dosage forms. (2012) Journal of Pharmacy and Pharmacology, 64(7), pp 986-996. http://dx.doi.org/10.1111/j.2042-7158.2012.01482.x
  40. M. Kapoor, D.J. Burgess. Physicochemical characterization of anionic lipid-based ternary siRNA-complexes, Biochimica et Biophysica Acta-Biomembranes, (2012),1818 (7), 1603-1612. http://dx.doi.org/10.1016/j.bbamem.2012.03.013
  41. X. Xu, A. Costa, D.J. Burgess. Protein Encapsulation in Unilamellar Liposomes: High Encapsulation Efficiency and A Novel Technique to Assess Lipid-Protein Interaction. (2012) Pharm Res., 29(7), 1919-1931. http://dx.doi.org/10.1007/s11095-012-0720-x
  42. X. Xu, M.A. Khan, D.J. Burgess. A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes. (2012) Int J Pharm, 426 (1-2), pp. 211-218. http://dx.doi.org/10.1016/j.ijpharm.2012.01.030
  43. X. Xu, M.A. Khan, D.J. Burgess. A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale. (2012) Int J Pharm, 423(2), pp. 543-553. http://dx.doi.org/10.1016/j.ijpharm.2011.11.036
  44. X. Xu, M.A. Khan, D.J. Burgess. Predicting hydrophilic drug encapsulation inside unilamellar liposomes. (2012) Int J Pharm, 423(2), pp. 410-418. http://dx.doi.org/10.1016/j.ijpharm.2011.12.019
  45. M. Kapoor, D.J. Burgess, S.D. Patil. Physicochemical characterization techniques for lipid based delivery systems for siRNA. (2012) Int J Pharm. 427(1), Pg 35-57 http://dx.doi.org/10.1016/j.ijpharm.2011.09.032
  46. J. Shen, D.J. Burgess. Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings. (2012) Int J Pharm, 422 (1-2), pp. 341-348. http://dx.doi.org/10.1016/j.ijpharm.2011.10.020
  47. A. Rawat, E. Strippler, V.P. Shah, D.J. Burgess. Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal® Consta®. (2011) Int J Pharm, 420 (2), pp. 198-205. http://dx.doi.org/10.1016/j.ijpharm.2011.08.035
  48. X. Xu, M.A. Khan, D.J. Burgess. A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment. (2011) Int J Pharm, 419 (1-2), pp. 52-59. http://dx.doi.org/10.1016/j.ijpharm.2011.07.012
  49. A. Rawat, D.J. Burgess. Effect of physical ageing on the performance of dexamethasone loaded PLGA microspheres. (2011) Int J Pharm, 415 (1-2), pp. 164-168. http://dx.doi.org/10.1016/j.ijpharm.2011.05.067
  50. A. Rawat, D.J. Burgess. USP apparatus 4 method for in vitro release testing of protein loaded microspheres. (2011) Int J Pharm, 409 (1-2), pp. 178-184. http://dx.doi.org/10.1016/j.ijpharm.2011.02.057
  51. S. Verma, S. Kumar, R. Gokhale, D.J. Burgess. Physical stability of nanosuspensions: Investigation of the role of stabilizers on Ostwald ripening. (2011) Int J Pharm, 406 (1-2), pp. 145-152. http://dx.doi.org/10.1016/j.ijpharm.2010.12.027.
  52. J.M. Morais, P.A. Rocha-Filho, D.J. Burgess. Relationship between rheological properties and one-step W/O/W multiple emulsion formation. Langmuir. 2010;26(23) 17874-17881. http://dx.doi.org/10.1021/la103358n.
  53. S. Vaddiraju, D.J. Burgess, I. Tomazos, F.C. Jain, F. Papadimitrakopoulos. Technologies for Continuous Glucose Monitoring: Current Problems and Future Promises. J. Diabetes Sci Technol. 2010;4(6): 1540-1562. http://www.ncbi.nlm.nih.gov/pubmed/21129353.
  54. I.T. Degim, D.J. Burgess, F. Papadimitrakopoulos. Carbon nanotubes for transdermal drug delivery (2010) Journal of Microencapsulation, 27 (8), pp. 669-681. http://dx.doi.org/10.3109/02652048.2010.506581
  55. A. Rawat and D.J. Burgess. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics. Int J Pharm. 2010;394(1-2):99-105.  http://dx.doi.org/10.1016/j.ijpharm.2010.05.013.
  56. J.M. Morais, F. Papadimitrakopoulos, D.J. Burgess. Biomaterials/tissue interactions: Possible solutions to overcome foreign body response. AAPS Journal. 2010;12(2):188-96. http://dx.doi.org/10.1208/s12248-010-9175-3. Cited by 1.
  57. U. Bhardwaj, D.J. Burgess. A novel USP apparatus 4 based release testing method for dispersed systems. Int J Pharm. 2010;388(1-2):287-94. http://dx.doi.org/10.1016/j.ijpharm.2010.01.009.
  58. U. Bhardwaj, D.J. Burgess. Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone. Int J Pharm. 2010;388(1-2):181-9. http://dx.doi.org/10.1016/j.ijpharm.2010.01.003. Cited by 1.
  59. M.N. Martinez, M.J. Rathbone, D.J. Burgess, M. Huynh. Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products. J Controlled Release. 2010;142(1):2-7. http://dx.doi.org/10.1016/j.jconrel.2009.09.028. Cited by 2.
  60. U. Bhardwaj, R. Sura, F. Papadimitrakopoulos, D.J. Burgess. PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation. Int J Pharm. 2010;384(1-2):78-86. http://dx.doi.org/10.1016/j.ijpharm.2009.09.046. Cited by 1.
  61. S. Vaddiraju, D.J. Burgess, F.C. Jain, F. Papadimitrakopoulos, Enhanced glucose sensor linearity using PVA hydrogels, JDST. 2009. 3(4) 863-874. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769944/.
  62. S. Vaddiraju, I. Tomazos, D.J. Burgess, F.C. Jain, F. Papadimitrakopoulos. Emerging synergy between nanotechnology and implantable biosensors: A review. Biosensors and Bioelectronics. 2009. http://dx.doi.org/10.1016/j.bios.2009.12.001. Cited by 9.
  63. S. Verma, B.D. Huey, D.J. Burgess. Scanning probe microscopy method for nanosuspension stabilizer selection. Langmuir. 2009;25(21):12481-7.http://dx.doi.org/10.1021/la9016432.
  64. S. Verma, R. Gokhale, D.J. Burgess. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm. 2009;380(1-2):216-22. http://dx.doi.org/10.1016/j.ijpharm.2009.07.005. Cited by 4.
  65. H. Kim, J. Gao, D.J. Burgess. Evaluation of solvent effects on protonation using NMR spectroscopy: Implication in salt formation. Int J Pharm. 2009;377(1-2):105-11. http://dx.doi.org/10.1016/j.ijpharm.2009.05.018. Cited by 3.
  66. S. Verma, Y. Lan, R. Gokhale, D.J. Burgess. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm. 2009;377(1-2):185-98. http://dx.doi.org/10.1016/j.ijpharm.2009.05.006. Cited by 2.
  67. J.M. Morais, P.A. Rocha-Filho, D.J. Burgess. Influence of phase inversion on the formation and stability of one-step multiple emulsions. Langmuir. 2009;25(14):7954-61. http://dx.doi.org/10.1021/la9007125. Cited by 2.
  68. C. Srinivasan, D.J. Burgess. Optimization and characterization of anionic lipoplexes for gene delivery. J Controlled Release. 2009;136(1):62-70.http://dx.doi.org/10.1016/j.jconrel.2009.01.022. Cited by 4.
  69. M.J. Rathbone, M.N. Martinez, M. Huynh, D.J. Burgess. CRS/AAPS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained-release products. Dissolution Technologies. 2009;16(2):55-6.http://www.dissolutiontech.com/DTresour/200905Articles/DT200905_A07.pdf.
  70. S. Vaddiraju, D.J. Burgess, F.C. Jain, F. Papadimitrakopoulos. The role of H2O2 outer diffusion on the performance of implantable glucose sensors. Biosensors and Bioelectronics. 2009;24(6):1557-62. http://dx.doi.org/10.1016/j.bios.2008.08.015. Cited by 2.
  71. W.W. Hauck, A.J. DeStefano, W.E. Brown, E. Stippler, D.R. Abernethy, R.L. Williams, T.S. Foster, J.E. Polli, D.J. Burgess, G.B. Crist, M.A. Gonzalez, V.A. Gray, J. Kraemer, L.J. Leeson, A.F. Parr, L. Shargel, E. Shefter, W.C. Simon, N.L. Tran, C.T. Ueda. Description of the upcoming change in data analysis for USP dissolution performance verification tests. Dissolution Technologies. 2009;16(1):7-12. http://www.setecltd.kr/info/Application/NewPQ.pdf. Cited by 2.
  72. C. Srinivasan, S. Siddiqui, L.K. Silbart, F. Papadimitrakopoulos, D.J. Burgess. Dual fluorescent labeling method to visualize plasmid DNA degradation. Bioconjug Chem. 2009;20(1):163-9. http://dx.doi.org/10.1021/bc800184j. Cited by 1.
  73. U. Bhardwaj, F. Papadimitrakopoulos, and D.J. Burgess. A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors. JDSAT. (2008): 2(6): 1016-1029. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769817. Cited by 2.
  74. Y. Onuki, U. Bhardwaj, F. Papadimitrakopoulos, and D.J. Burgess. Biocompatibility of implantable devices: Current challenges to overcome foreign body response. JDSAT. (2008): 2(6): 1003-1015. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769826/. Cited by 7.
  75. W.W. Hauck, A.J. DeStefano, W.E. Brown, E. StipplerS, D.R. Abernethy, R.L. Williams, T.S. Foster, J.E. Polli, D.J. Burgess, G.B. Crist, M.A. Gonzalez, V.A. Gray, J. Kraemer, L.J. Leeson, A.F. Parr, L. Shargel, E. Shefter, W.C. Simon, N.L. Tran, C.T. Ueda. Description of the upcoming change in data analysis for USP dissolution performance verification tests. Pharmacop Forum. 2008;34(6):1630-4. Cited by 1.
  76. M. Martinez, M. Rathbone, D.J. Burgess, M. Huynh. In vitro and in vivo considerations associated with parenteral sustained release products: A review based upon information presented and points expressed at the 2007 controlled release society annual meeting. J Controlled Release. 2008;129(2):79-87. http://dx.doi.org/10.1016/j.jconrel.2008.04.004. Cited by 13.
  77. J.M. Voisine, B.S. Zolnik, D.J. Burgess. In situ fiber optic method for long-term in vitro release testing of microspheres. Int J Pharm. 2008;356(1-2):206-11. http://dx.doi.org/10.1016/j.ijpharm.2008.01.017. Cited by 1.
  78. B.S. Zolnik, D.J. Burgess. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Controlled Release. 2008;127(2):137-45. http://dx.doi.org/10.1016/j.jconrel.2008.01.004. Cited by 24.
  79. B.S. Zolnik, D.J. Burgess. Effect of acidic pH on PLGA microsphere degradation and release. J Controlled Release. 2007;122(3):338-44.  http://dx.doi.org/10.1016/j.jconrel.2007.05.034. Cited by 35.
  80. U. Bhardwaj, R. Sura, F. Papadimitrakopoulos, and D.J. Burgess. Controlling acute Inflammation with fast-releasing dexamethasone-PLGA microsphere/PVA hydrogel composites for implantable devices.  Journal of Diabetes Science and Technology 2007. 1(1):8-17. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769608. Cited by 10.
  81. R. Tipnis, S. Vaddiraju, F.C. Jain, D.J. Burgess and F. Papadimitrakopoulos.  Layer-by-layer assembled semi-permeable membrane for amperometric glucose sensors. Journal of Diabetes Science and Technology 2007. 1(1):193-200. http://www.ncbi.nlm.nih.gov/sites/ppmc/articles/PMC2771465. Cited by 4.
  82. S.D. Patil, F. Papadimitrakopoulos, D.J. Burgess. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Controlled Release. 2007;117(1):68-79. http://dx.doi.org/10.1016/j.jconrel.2006.10.013. Cited by 46.
  83. M. Zhao, C. Srinivasan, D.J. Burgess, B.D. Huey. Rate- and depth-dependent nanomechanical behavior of individual living chinese hamster ovary cells probed by atomic force microscopy. J Mater Res. 2006;21(8):1906-12. http://www.mrs.org/s_mrs/sec_subscribe.asp?CID=6822&DID=177200&action=detail.
  84. C. Srinivasan, J. Lee, F. Papadimitrakopoulos, L.K. Silbart, M. Zhao, D.J. Burgess. Labeling and intracellular tracking of functionally active plasmid DNA with semiconductor quantum dots. Molecular Therapy. 2006;14(2):192-201. http://dx.doi.org/10.1016/j.ymthe.2006.03.010. Cited by 38.
  85. B.S. Zolnik, P.E. Leary, D.J. Burgess. Elevated temperature accelerated release testing of PLGA microspheres. J Controlled Release. 2006;112(3):293-300. http://dx.doi.org/10.1016/j.jconrel.2006.02.015. Cited by 31.
  86. D.J. Burgess, B.C. Clark, M.J. Hampson-Carlin, P. Shah. Critical Quality and Performance Parameters for Modified-Release Parenteral Dosage Forms. Pharmacopeial Forum. 31(6) [Nov–Dec. 2005]:1745.
  87. C. Srinivasan and D.J. Burgess. Anionic lipid-based gene delivery system. Journal of Science & Technology. 2005 Oct; 1(2):7- 11.
  88. K. Regnstrom, D.J. Burgess. Pharmacogenomics and its potential impact on drug and formulation development. Crit Rev Ther Drug Carrier Syst. 2005;22(5):465-92. http://www.ncbi.nlm.nih.gov/pubmed/16313234. Cited by 10.
  89. Galeska, T-K. Kim, S.D. Patil, U. Bhardwaj, D. Chattopadhyay, F. Papadimitrakopoulos, D.J. Burgess. Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels. AAPS Journal. 2005;7(1):E231-40. http://dx.doi.org/10.1208/aapsj070122. Cited by 34.
  90. A.D. Asandei, C. Erkey, D.J. Burgess, C. Saquing, G. Saha, B.S. Zolnik. Preparation of drug delivery biodegradable PLGA nanocomposites and foams by supercritical CO2 expanded ring opening polymerization and by rapid expansion from CHClF2 supercritical solutions. Material Research Society. 2005. p. 243-8. http://www.mrs.org/s_mrs/bin.asp?CID=2710&DID=61753&DOC=FILE.PDF. Cited by 1.
  91. S.D. Patil, D.G. Rhodes, D.J. Burgess. Biophysical characterization of anionic lipoplexes. Biochimica et Biophysica Acta - Biomembranes. 2005;1711(1):1-11. http://dx.doi.org/10.1016/j.bbamem.2005.03.004. Cited by 24.
  92. B.S. Zolnik, J-L. Raton, and D.J. Burgess.  Application of USP apparatus 4 and in situ fiber optic monitoring to microspheres release testing.  Dissolution Technologies. 2005; 12(2):11-14. http://www.dissolutiontech.com/DTresour/200505Articles/DT200505_A02.pdf. Cited by 6.
  93. S.D. Patil, D.G. Rhodes, D.J. Burgess. DNA-based therapeutics and DNA delivery systems: A comprehensive review. AAPS Journal. 2005;7(1):E61-77. http://dx.doi.org/10.1208/aapsj070109. Cited by 177.
  94. A.D. Asandei, C. Erkey, D.J. Burgess, C. Saquing, G. Saha and B.S. Zolnik.  Preparation of drug delivery biodegradable nanocomposites by rapid expansion form supercritical solutions.  Polymer Preprints. 2004; 45(2):770 -771.
  95. A.D. Asandei, C. Erkey, D.J. Burgess, C. Saquing, G. Saha and B.S. Zolnik.  Synthesis of PLGA foams by high temperature supercritical CO2 expanded ring opening copolymerization of D,L-Lactide and Glycolide.  Polymer Preprints. 2004; 45(2):1014 - 1015. Cited by 2.
  96. D.J. Burgess, D.J.A. Crommelin, A.S. Hussain, M. Chen. Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report. AAPS Journal. 2004;6(1):XIII-XIV. http://dx.doi.org/10.1208/ps060111.  Cited by 17.
  97. D.J. Burgess, E. Duffy, F. Etzler, A.J. Hickey. Particle size analysis: AAPS workshop report, cosponsored by the food and drug administration and the united states pharmacopeia. AAPS Journal. 2004;6(3). http://dx.doi.org/10.1208/aapsj060320. Cited by 9.
  98. S.D. Patil, F. Papadimitrakopoulos, D.J. Burgess. Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technology and Therapeutics. 2004;6(6):887-97. http://dx.doi.org/10.1089/dia.2004.6.887.  Cited by 29.
  99. S.D. Patil, D.G. Rhodes, D.J. Burgess. Anionic liposomal delivery system for DNA transfection. AAPS Journal. 2004;6(4). http://dx.doi.org/10.1208/aapsj060429.
  100. D.J. Burgess, D.J.A. Crommelin, A.S. Hussain, M. Chen. Assuring quality and performance of sustained and controlled release parenterals. European Journal of Pharmaceutical Sciences. 2004;21(5):679-90. http://dx.doi.org/10.1016/j.ejps.2004.03.001. Cited by 18.
  101. J. Jiao, D.J. Burgess. Rheology and stability of water-in-oil-in-water multiple emulsions containing span 83 and tween 80. AAPS PharmSci. 2003;5(1). http://dx.doi.org/10.1208/ps050107. Cited by 25.
  102. M. Siewert, J. Dressman, C.K. Brown, V.P. Shah, J. Aiache, N. Aoyagi, D. Bashaw, W. Brown, D.J. Burgess, J. Crison, P. DeLuca, R. Djerki, T. Foster, K. Gjellan, V. Gray, A. Hussain, T. Ingallinera, J. Klancke, J. Kraemer, H. Kristensen, K. Kumi, C. Leuner, J. Limberg, P. Loos, L. Margulis, P. Marroum, H. Moeller, B. Mueller, M. Mueller-Zsigmondy, N. Okafo, L. Ouderkirk, S. Parsi, S. Qureshi, J. Robinson, R. Uppoor, R. Williams. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech. 2003;4(1). http://www.aapspharmscitech.org/articles/pt0401/pt040107/pt040107.pdf.
  103. N.O. Sahin, D.J. Burgess. Competitive interfacial adsorption of blood proteins. Farmaco. 2003;58(10):1017-21. http://dx.doi.org/10.1016/S0014-827X(03)00183-6. Cited by 1.
  104. J. Jiao, D.J. Burgess. Ostwald ripening of water-in-hydrocarbon emulsions. J Colloid Interface Sci. 2003;264(2):509-16. http://dx.doi.org/10.1016/S0021-9797(03)00276-5. Cited by 8.
  105. J. Bu, Y. Song, G. Rompato, D.J. Burgess, A.E. Garmendia. Co-delivery of IL-2 or liposomes augment the responses of mice to a DNA vaccine for pseudorabies virus IE180. Comp Immunol Microbiol Infect Dis. 2003;26(3):175-87. http://dx.doi.org/10.1016/S0147-9571(02)00050-4. Cited by 16.
  106. D.J. Burgess, A.S. Hussain, T.S. Ingallinera, M. Chen. Assuring quality and performance of sustained and controlled release parenterals: Workshop report. AAPS PharmSci. 2002;4(2). http://dx.doi.org/10.1208/ps060111.  Cited by 44.
  107. D.J. Burgess, A.S. Hussain, T.S. Ingallinera, M. Chen. Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP. Pharm Res. 2002;19(11):1761-8. http://dx.doi.org/10.1023/A:1020730102176. Cited by 13.
  108. J. Jiao, D.G. Rhodes, D.J. Burgess. Multiple emulsion stability: Pressure balance and interfacial film strength. J Colloid Interface Sci. 2002;250(2):444-50. http://dx.doi.org/10.1006/jcis.2002.8365. Cited by 34.
  109. H. Kim, D.J. Burgess. Effect of drug stability on the analysis of release data from controlled release microspheres. J Microencapsul. 2002;19(5):631-40. http://dx.doi.org/10.1080/02652040210140698. Cited by 6.
  110. T. Kim, D.J. Burgess. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J Pharm Pharmacol. 2002;54(7):897-905. http://dx.doi.org/10.1211/002235702760089009. Cited by 38.
  111. T. Hickey, D. Kreutzer, D.J. Burgess, F. Moussy. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res. 2002;61(2):180-7. http://dx.doi.org/10.1002/jbm.10016. Cited by 59.
  112. T. Hickey, D. Kreutzer, D.J. Burgess, F. Moussy. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials. 2002;23(7):1649-56. http://dx.doi.org/10.1016/S0142-9612(01)00291-5. Cited by 71.
  113. M.J. Tsung, D.J. Burgess. Preparation and characterization of gelatin surface modified PLGA microspheres. AAPS PharmSci. 2001;3(2). http://www.springerlink.com/content/u212070226x5828x. Cited by 22.
  114. H. Kim, D.J. Burgess. Prediction of interfacial tension between oil mixtures and water. J Colloid Interface Sci. 2001;241(2):509-13. http://dx.doi.org/10.1006/jcis.2001.7655. Cited by 7.
  115. J. Bennett, J. Gross, F. Nichols, N. Chidambaram, D.J. Burgess. The chemical and physical stability of a 1:1 mixture of propofol and methohexital. Anesthesia Progress. 2001; 48(2):61. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2007364. Cited by 1.
  116. N. Chidambaram, D.J. Burgess. Effect of phenylazoaniline to cetyltrimethyl-ammonium bromide ratio on micellar shape. Colloids Surf Physicochem Eng Aspects. 2001;181(1-3):271-8. http://dx.doi.org/10.1016/S0927-7757(00)00807-4. Cited by 3.
  117. T. Kim, D.J. Burgess. Formulation and release characteristics of poly(lactic-co-glycolic acid) microspheres containing chemically modified protein. J Pharm Pharmacol. 2001;53(1):23-31. http://dx.doi.org/10.1211/0022357011775154. Cited by 15.
  118. D. Lu, D.J. Burgess, D.G. Rhodes. Nonideality in mixed monolayers of sorbitan oleates is enhanced by elevated ionic strength. Langmuir. 2000;16(26):10329-33. http://dx.doi.org/10.1021/la001058u. Cited by 4.
  119. N. Chidambaram, D.J. Burgess. Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems. AAPS pharmSci. 2000;2(3). http://www.aapsj.org/view.asp?art=ps020328. Cited by 5.
  120. J. Bu, Y. Song, D.J. Burgess, A.E. Garmendia. Increased immunogenicity of a DNA vaccine encoding pseudorabies virus IE 180 protein by co-administration of IL-2 or by delivery in liposome. Vet. Res. 2000; 31:138-139. http://dx.doi.org/10.1051/vetres:2000011.
  121. N. Chidambaram, D.J. Burgess. Mathematical modeling of surface-active and non-surface-active drug transport in emulsion systems. AAPS PharmSci. 2000;2(3):1-12. http://dx.doi.org/10.1208/ps020331. Cited by 3.
  122. N. Chidambaram, D.J. Burgess. Effect of nonionic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems. AAPS PharmSci. 2000;2(3):1-11. http://dx.doi.org/10.1208/ps020330. Cited by 6.
  123. N. Chidambaram, D.J. Burgess. A novel in vitro release method for submicron-sized dispersed systems. AAPS PharmSci. 1999;1(3):1-9. http://dx.doi.org/10.1208/ps010311. Cited by 16.
  124. D.J. Burgess, S. Ponsart. β-Glucuronidase activity following complex coacervation and spray drying microencapsulation. J Microencapsul. 1998;15(5):569-79. http://dx.doi.org/10.3109/02652049809008241. Cited by 11.
  125. F.O. Opawale, D.J. Burgess. Influence of interfacial rheological properties of mixed emulsifier films on the stability of water-in-oil-in-water emulsions. J Pharm Pharmacol. 1998;50(9):965-73. http://www.ncbi.nlm.nih.gov/pubmed/9811156. Cited by 30.
  126. D.J. Burgess, O.N. Sahin. Influence of protein emulsifier interfacial properties on oil-in-water emulsion stability. Pharm Dev Technol. 1998;3(1):21-9. http://dx.doi.org/10.3109/10837459809028476. Cited by 4.
  127. K.A. Yoon, D.J. Burgess. Mathematical modelling of drug transport in emulsion systems. J Pharm Pharmacol. 1998;50(6):601-10.  http://www.ncbi.nlm.nih.gov/pubmed/9680069. Cited by 9.
  128. F.O. Opawale, D.J. Burgess. Influence of interfacial properties of lipophilic surfactants on water- in-oil emulsion stability. J Colloid Interface Sci. 1998;197(1):142-50. http://dx.doi.org/10.1006/jcis.1997.5222. Cited by 64.
  129. D.J. Burgess, N.O. Sahin. Interfacial rheological and tension properties of protein films. J Colloid Interface Sci. 1997;189(1):74-82. http://dx.doi.org/10.1006/jcis.1997.4803. Cited by 30.
  130. K.A. Yoon, D.J. Burgess. Effect of cationic surfactant on transport of model drugs in emulsion systems. J Pharm Pharmacol. 1997;49(5):478-84. http://www.ncbi.nlm.nih.gov/pubmed/9178180. Cited by 15.
  131. M.J. Tsung, D.J. Burgess. Preparation and stabilization of heparin/gelatin complex coacervate microcapsules. J Pharm Sci. 1997;86(5):603-7. http://dx.doi.org/10.1021/js9603257. Cited by 34.
  132. J.K. Yoon, D.J. Burgess. Interfacial properties as stability predictors of lecithin-stabilized perfluorocarbon emulsions. Pharm Dev Technol. 1996;1(4):333-41. http://www.ncbi.nlm.nih.gov/pubmed/9552317. Cited by 9.
  133. S.M. Abraham, R.F. Vieth, D.J. Burgess. Novel technology for the preparation of sterile alginate-poly-l-lysine microcapsules in a bioreactor. Pharm Dev Technol. 1996;1(1):63-8. http://dx.doi.org/10.3109/10837459609031419. Cited by 11.
  134. O.N. Singh, D.J. Burgess. Development of a novel method of microencapsulation for a model protein, β-glucuronidase. Pharmaceutical Sciences. 1996;2(5):223-8. Cited by 6.
  135. K.A. Yoon, D.J. Burgess. Effect of nonionic surfactant on transport of model drugs in emulsions. Pharm Res. 1996;13(3):433-9. http://dx.doi.org/10.1023/A:1016052811789. Cited by 12.
  136. D.J. Burgess, J.K. Yoon. Influence of interfacial properties on perfluorocarbon/aqueous emulsion stability. Colloids and Surfaces B: Biointerfaces. 1995;4(5):297-308. http://dx.doi.org/10.1016/0927-7765(94)01179-9. Cited by 8.
  137. D.J. Burgess, O.N. Singh, M. Horn. Effect of microencapsulation on β-glucuronidase stability. Proceedings of the Controlled Release Society. 1994(21):280-1.
  138. M. Rabiskova, J. Song, F.O. Opawale, D.J. Burgess. The influence of surface properties on uptake of oil into complex coacervate microcapsules. J Pharm Pharmacol. 1994;46(8):631-5. http://www.ncbi.nlm.nih.gov/pubmed/7815274. Cited by 11.
  139. N. Milman, J.K. Yoon, A.J. Hickey, D.J. Burgess. Comparison of contact angle measurements by three methods. Colloids and Surfaces B: Biointerfaces. 1993;1(5):315-21. http://dx.doi.org/10.1016/0927-7765(93)80006-K. Cited by 4.
  140. D.J. Burgess, J.K. Yoon. Interfacial tension studies on surfactant systems at the aqueous/perfluorocarbon interface. Colloids and Surfaces B: Biointerfaces. 1993;1(5):283-93. http://dx.doi.org/10.1016/0927-7765(93)80003-H. Cited by 3.
  141. D.J. Burgess and O.N. Singh. Spontaneous formation of small sized albumin/acacia coacervate microcapsules.  J. Pharm. Pharmac. 1993; 45:586-59. http://www.ncbi.nlm.nih.gov/pubmed/8105049. Cited by 24.
  142. D.J. Burgess, J.K. Yoon, N.O. Sahin. A novel method of determination of protein stability. Journal of Parenteral Science and Technology. 1992;46(5):150-5. http://www.ncbi.nlm.nih.gov/pubmed/1432452. Cited by 8.
  143. J.K. Yoon, D.J. Burgess. Comparison of dynamic and static interfacial tension at aqueous/perfluorocarbon interfaces. J Colloid Interface Sci. 1992;151(2):402-9. http://dx.doi.org/10.1016/0021-9797(92)90489-9. Cited by 6.
  144. K.K. Kwok, D.J. Burgess. A novel method for determination of sterility of microcapsules and measurement of viability of encapsulated organisms. Pharm Res. 1992;9(3):410-3. http://dx.doi.org/10.1023/A:1015859406588. Cited by 8.
  145. K.K. Kwok, M.J. Groves, D.J. Burgess. Production of 5-15 μm diameter alginate-polylysine microcapsules by an air-atomization technique. Pharm Res. 1991;8(3):341-4. http://dx.doi.org/10.1023/A:1015841531372. Cited by 62.
  146. D.J. Burgess, T.A. Marek, K.K. Kwok, O.N. Singh. Complex coacervation: Spontaneous microcapsule formation. Polymer Preprints. 1991; April; p.600.
  147. D.J. Burgess, L. Longo, J.K. Yoon. A novel method of assessment of interfacial adsorption of blood proteins. Journal of Parenteral Science and Technology. 1991;45(5):239-45. http://www.ncbi.nlm.nih.gov/pubmed/1753315. Cited by 3.
  148. D.J. Burgess, K.K. Kwok, P.T. Megremis. Characterization of albumin-acacia complex coacervation. J Pharm Pharmacol. 1991;43(4):232-6. http://www.ncbi.nlm.nih.gov/pubmed/1676733. Cited by 14.
  149. D.J. Burgess. Practical analysis of complex coacervate systems. J Colloid Interface Sci. 1990;140(1):227-38. http://dx.doi.org/10.1016/0021-9797(90)90338-O.
  150. O.N. Singh, D.J. Burgess. Characterization of albumin-alginic acid complex coacervation. J Pharm Pharmacol. 1989;41(10):670-3. http://www.ncbi.nlm.nih.gov/pubmed/2575142 Cited by 26.
  151. D.J. Burgess, S.S. Davis. Potential use of albumin microspheres as a drug delivery system. II. in vivo deposition and release of steroids. Int J Pharm. 1988;46(1-2):69-76. http://dx.doi.org/10.1016/0378-5173(88)90011-7. Cited by 11.
  152. D.J. Burgess, S.S. Davis, E. Tomlinson. Potential use of albumin microspheres as a drug delivery system. I. preparation and in vitro release of steroids. Int J Pharm. 1987;39(1-2):129-36. http://dx.doi.org/10.1016/0378-5173(87)90207-9. Cited by 33.
  153. D.J. Burgess, J.E. Carless. Microelectrophoretic behaviour of gelatin and acacia complex coacervates and indomethacin microcapsules. Int J Pharm. 1986;32(2-3):207-12. http://dx.doi.org/10.1016/0378-5173(86)90180-8Cited by 3.
  154. D.J. Burgess, J.E. Carless. Manufacture of gelatin/gelatin coacervate microcapsules. Int J Pharm. 1985;27(1):61-70. http://dx.doi.org/10.1016/0378-5173(85)90185-1. Cited by 26.
  155. D.J. Burgess and J.E. Carless. Microelectrophoretic studies of gelatin and acacia for the prediction of complex coacervation.  J. Coll. Interface Sci. 1984; 98:1‑8.  http://dx.doi.org/10.1016/0021-9797(84)90472-7. Cited by 46.